Drug profile · INN
clonidine hydrochloride
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride (CLONIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — clonidine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
clonidine hydrochloride (CLONIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is clonidine hydrochloride?
clonidine hydrochloride (CLONIDINE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for clonidine hydrochloride?
CLONIDINE HYDROCHLORIDE is a marketed brand name for clonidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clonidine hydrochloride?
clonidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.